Skip to content

Net Income at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$293.1M+417%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$102.3M-57.3%
Biogen logo
BiogenBIIB
$319.5M+32.8%
Alkermes logo
AlkermesALKS
-$66.48M-396%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$197.9M+2,405%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-$64.54M-8.6%

Segments

By segment

See full
Reportable Segment-$92.56M-33.6%

Other financials

Income statement

See full
Revenue--100%
Operating income-$105.9M-41.7%
Net income-$92.6M-33.6%
EPS (diluted)-$3.20+2.7%

Balance sheet

See full
Cash & equivalents$536.7M+223%
Total debt$1.4M+31.3%
Total equity$1.4B+221%
Total assets$1.5B+205%

Cash flow

See full
Operating cash flow-$86.2M-62.5%
CapEx$62.0K
Free cash flow-$86.2M-62.6%

Valuation

See full
Market cap$7.87B+1,075%
Enterprise value$7.34B+1,309%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-35.3%-10.9pp
Debt / equity0.0×
Current ratio15.9×+7.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s net income?
Praxis Precision Medicines, Inc. (PRAX) reported net income of -$92.56M in Q1 2026.
How has Praxis Precision Medicines, Inc.'s net income changed year-over-year?
Praxis Precision Medicines, Inc.'s net income decreased by 33.6% year-over-year, from -$69.3M to -$92.56M.
What is the long-term trend for Praxis Precision Medicines, Inc.'s net income?
Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s net income has grown at a 16.1% compound annual growth rate (CAGR), from -$167.06M to -$303.27M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.